SCHEMBL18308785

SCHEMBL18308785

Cc1cc(P)ccc1-c1cccc(-c2ccc(CP)cc2C)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR7 P34969 2/20 0.37
▸ ESR2 Q92731 2/20 0.36
▸ FFAR1 O14842 4/20 0.34
▸ ALDH2 P05091 1/20 0.33
▸ AKR1C3 P42330 1/20 0.32
▸ AKR1C2 P52895 1/20 0.32
▸ L3MBTL1 Q9Y468 1/20 0.32
▸ ADORA2A P29274 1/20 0.32
▸ ADORA1 P30542 1/20 0.32
▸ PPARG P37231 1/20 0.31
▸ PPARA Q07869 1/20 0.31
▸ CYP1A1 P04798 1/20 0.31
▸ CYP1A2 P05177 1/20 0.31
▸ CYP2E1 P05181 1/20 0.31
▸ CYP3A4 P08684 1/20 0.31
▸ CYP2C8 P10632 1/20 0.31
▸ CYP2D6 P10635 1/20 0.31
▸ CYP2A6 P11509 1/20 0.31
▸ CYP2C9 P11712 1/20 0.31
▸ CYP4B1 P13584 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18308810 0.92 HTR7 (0.35) HTR7ESR2FFAR1AKR1C3AKR1C2
SCHEMBL18308778 0.90 HTR7 (0.36) HTR7ESR2FFAR1ALDH2ESR1
SCHEMBL18308755 0.90 RARB (0.35) ESR2PPARGPPARAESR1WNT3A
SCHEMBL18806015 0.89 HTR7 (0.38) HTR7ESR2FFAR1AKR1C3AKR1C2
SCHEMBL18308728 0.84 RARB (0.36) ESR2PPARGPPARAESR1
SCHEMBL18308735 0.84 RARB (0.36) ESR2PPARGPPARAESR1WNT3A
SCHEMBL18308805 0.83 HTR7 (0.41) HTR7ESR2FFAR1ALDH2AKR1C3
SCHEMBL18308757 0.83 RARB (0.35) ESR2PPARGPPARAESR1WNT3A
SCHEMBL18308764 0.83 RARB (0.35) ESR2PPARGPPARAESR1
SCHEMBL18806012 0.83 ESR2 (0.33) HTR7ESR2AKR1C3AKR1C2ESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11718791-B2 Polymerisable compounds and the use thereof in liquid-crystal displays MERCK PATENT GMBH (DE) 2023-08-08 — — US disclosed
US-20170121606-A1 POLYMERIZABLE COMPOUNDS AND THE USE THEREOF IN LIQUID-CRYSTAL DISPLAYS GMBH, MERCK PATENT (DE) 2017-05-04 — — US disclosed
US-20160362606-A1 POLYMERIZABLE COMPOUNDS AND THE USE THEREOF IN LIQUID-CRYSTAL DISPLAYS MERCK PATENT GMBH (DE) 2016-12-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11718791-B2 Polymerisable compounds and the use thereof in liquid-crystal displays VCL, ILK, LCP1 HTR7 4174/4885ESR2 4146/4885FFAR1 4194/4885
US-20170121606-A1 POLYMERIZABLE COMPOUNDS AND THE USE THEREOF IN LIQUID-CRYSTAL DISPLAYS VCL, LCP1, MAP1LC3C HTR7 3960/4885ESR2 4322/4885FFAR1 3886/4885
US-20160362606-A1 POLYMERIZABLE COMPOUNDS AND THE USE THEREOF IN LIQUID-CRYSTAL DISPLAYS VCL, PLEC, EML4 HTR7 4122/4885ESR2 4381/4885FFAR1 3780/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback